| UniProt ID | TRI45_HUMAN | |
|---|---|---|
| UniProt AC | Q9H8W5 | |
| Protein Name | Tripartite motif-containing protein 45 | |
| Gene Name | TRIM45 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 580 | |
| Subcellular Localization | Cytoplasm . Nucleus . | |
| Protein Description | May act as a transcriptional repressor in mitogen-activated protein kinase signaling pathway.. | |
| Protein Sequence | MSENRKPLLGFVSKLTSGTALGNSGKTHCPLCLGLFKAPRLLPCLHTVCTTCLEQLEPFSVVDIRGGDSDTSSEGSIFQELKPRSLQSQIGILCPVCDAQVDLPMGGVKALTIDHLAVNDVMLESLRGEGQGLVCDLCNDREVEKRCQTCKANLCHFCCQAHRRQKKTTYHTMVDLKDLKGYSRIGKPILCPVHPAEELRLFCEFCDRPVCQDCVVGEHREHPCDFTSNVIHKHGDSVWELLKGTQPHVEALEEALAQIHIINSALQKRVEAVAADVRTFSEGYIKAIEEHRDKLLKQLEDIRAQKENSLQLQKAQLEQLLADMRTGVEFTEHLLTSGSDLEILITKRVVVERLRKLNKVQYSTRPGVNDKIRFCPQEKAGQCRGYEIYGTINTKEVDPAKCVLQGEDLHRAREKQTASFTLLCKDAAGEIMGRGGDNVQVAVVPKDKKDSPVRTMVQDNKDGTYYISYTPKEPGVYTVWVCIKEQHVQGSPFTVMVRRKHRPHSGVFHCCTFCSSGGQKTARCACGGTMPGGYLGCGHGHKGHPGHPHWSCCGKFNEKSECTWTGGQSAPRSLLRTVAL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSENRKPLL ------CCCCCCCCH | 43.51 | 26074081 | |
| 13 | Phosphorylation | KPLLGFVSKLTSGTA CCCHHHHHHHCCCCC | 21.49 | 26074081 | |
| 50 | Phosphorylation | PCLHTVCTTCLEQLE HHHHHHHHHHHHHCC | 19.06 | 18452278 | |
| 168 | Phosphorylation | AHRRQKKTTYHTMVD HHHHCCCCEEEEEEE | 39.35 | 29083192 | |
| 169 | Phosphorylation | HRRQKKTTYHTMVDL HHHCCCCEEEEEEEH | 23.37 | 29083192 | |
| 170 | Phosphorylation | RRQKKTTYHTMVDLK HHCCCCEEEEEEEHH | 10.67 | 29083192 | |
| 172 | Phosphorylation | QKKTTYHTMVDLKDL CCCCEEEEEEEHHHC | 14.42 | 29083192 | |
| 267 | Ubiquitination | HIINSALQKRVEAVA HHHHHHHHHHHHHHH | 31.09 | 22817900 | |
| 279 | Phosphorylation | AVAADVRTFSEGYIK HHHCCHHHHCHHHHH | 31.21 | 24275569 | |
| 306 | Ubiquitination | LEDIRAQKENSLQLQ HHHHHHHHHHCHHHH | 58.85 | 29967540 | |
| 371 | Ubiquitination | TRPGVNDKIRFCPQE CCCCCCCCEEECCHH | 30.49 | 22817900 | |
| 465 | Phosphorylation | QDNKDGTYYISYTPK EECCCCEEEEEECCC | 12.34 | 28331001 | |
| 466 | Phosphorylation | DNKDGTYYISYTPKE ECCCCEEEEEECCCC | 5.34 | 28331001 | |
| 470 | Phosphorylation | GTYYISYTPKEPGVY CEEEEEECCCCCCEE | 22.54 | 28331001 | |
| 491 | Phosphorylation | KEQHVQGSPFTVMVR EECCCCCCCEEEEEE | 10.35 | - | |
| 521 | Phosphorylation | CSSGGQKTARCACGG ECCCCCEEEEEECCC | 16.08 | - | |
| 551 | Phosphorylation | HPGHPHWSCCGKFNE CCCCCCCCCCCCCCC | 9.11 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI45_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI45_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI45_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| UB2D1_HUMAN | UBE2D1 | physical | 21143188 | |
| UB2D2_HUMAN | UBE2D2 | physical | 21143188 | |
| UB2D3_HUMAN | UBE2D3 | physical | 21143188 | |
| UB2D4_HUMAN | UBE2D4 | physical | 21143188 | |
| UB2E1_HUMAN | UBE2E1 | physical | 21143188 | |
| UB2E2_HUMAN | UBE2E2 | physical | 21143188 | |
| UB2E3_HUMAN | UBE2E3 | physical | 21143188 | |
| RACK1_HUMAN | GNB2L1 | physical | 24681954 | |
| TRI45_HUMAN | TRIM45 | physical | 24681954 | |
| UBE2B_HUMAN | UBE2B | physical | 24681954 | |
| P53_HUMAN | TP53 | physical | 28542145 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Ubiquitylation | |
| Reference | PubMed |
| "Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-371, AND MASSSPECTROMETRY. | |